Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect

被引：0
|
作者：
F. Puisset
E. Chatelut
A. Sparreboom
J.-P. Delord
D. Berchery
I. Lochon
T. Lafont
H. Roché
机构：
[1] EA3035,
[2] Institut Claudius-Regaud,undefined
[3] St. Jude Children’s Research Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Cytochrome P450 3A4/5; Dexamethasone; Docetaxel; Pharmacokinetics; Gender;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：305 / 308
页数：3
相关论文
共 50 条
  • [41] Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes
    Leel, Jin Sol
    Cheong, Hyun Sub
    Kim, Lyoung Hyo
    Kixn, Ji On
    Seo, Doo Won
    Kim, Young Hoon
    Chung, Myeon Woo
    Han, Soon Young
    Shin, Hyoung Doo
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2013, 17 (06) : 479 - 484
  • [42] The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients
    Zhai, Qinglian
    Moes, Dirk Jan A. R.
    van Gelder, Teun
    van Der Lee, Maaike
    Sanders, Jan-Stephan
    Bemelman, Frederike J.
    de Fijter, Johan W.
    Klein, Kathrin
    Schwab, Matthias
    Swen, Jesse J.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (02):
  • [43] PXR-mediated induction of human CYP3A4 and mouse Cyp3a11 by the glucocorticoid budesonide
    Zimmermann, Christian
    van Waterschoot, Robert A. B.
    Harmsen, Stefan
    Maier, Angelika
    Gutmann, Heike
    Schinkel, Alfred H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (4-5) : 565 - 571
  • [44] Monoester-Diterpene Aconitum Alkaloid Metabolism in Human Liver Microsomes: Predominant Role of CYP3A4 and CYP3A5
    Ye, Ling
    Yang, Xiao-Shan
    Lu, Lin-Lin
    Chen, Wei-Ying
    Zeng, Shan
    Yan, Tong-Meng
    Dong, Ling-Na
    Peng, Xiao-Juan
    Shi, Jian
    Liu, Zhong-Qiu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [45] The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects
    Marta Hamilton
    Julie L. Wolf
    Daniel W. Drolet
    Scott H. Fettner
    Ashok K. Rakhit
    Karsten Witt
    Bert L. Lum
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 613 - 621
  • [46] Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjects
    Hsyu, Poe-Hirr
    Pignataro, Daniela Soriano
    Matschke, Kyle
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (01) : 49 - 56
  • [47] The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects
    Hamilton, Marta
    Wolf, Julie L.
    Drolet, Daniel W.
    Fettner, Scott H.
    Rakhit, Ashok K.
    Witt, Karsten
    Lum, Bert L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (03) : 613 - 621
  • [48] EFFECT OF CRANBERRY DIETARY SUPPLEMENTS WITH DIFFERENT BRANDS ON HUMAN CYP3A4 ENZYME
    Wanwimolruk, Sompon
    Prachayasittikul, Supaluk
    Prachayasittikul, Virapong
    Bernichi, Bouchra
    EXCLI JOURNAL, 2012, 11 : 108 - 115
  • [49] Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjects
    Poe-Hirr Hsyu
    Daniela Soriano Pignataro
    Kyle Matschke
    European Journal of Clinical Pharmacology, 2017, 73 : 49 - 56
  • [50] Drug-Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects
    Chen, Jin
    Stringer, Rowan
    Shah, Bharti
    Gu, Jessie
    Zhang, Yiming
    Hackling, Melissa
    Prince, William
    Woessner, Ralph
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (11): : 1253 - 1263
12345